International Oncology Network - Cancer & Hematology News
Cora Sternberg describes an interesting phase III study confirming the positive results for a new drug in RCC treatment. This study was presented during ESMO 2012, the Congress of the European Society for Medical Oncology.
Tags: Cancer, Cell, ESMO, Oncozine, Pazopanib, More…RCC, Research, Trial, oncology, renal, survival
Sign Upor Sign In
Or sign in with:
Join the Conversation!
Pharmceutical Business News
© 2013 Created by Peter Hofland, PhD.
Report an Issue |
Terms of Service
Please check your browser settings or contact your system administrator.